World News: 21:30 GMT Thursday 6th December 2018. [SI-BONE, Inc. via Globe Newswire via SPi World News]
SANTA CLARA, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- SI-BONE, Inc., a medical device company that pioneered the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant System, today announced that Blue Cross Blue Shield of Arizona (BCBS AZ), based on published clinical evidence, has established a positive coverage policy for MIS SI joint fusion exclusively for the iFuse Implant System, effective November 20, 2018. All other SI joint fusion products are considered experimental and investigational and are not covered by the plan. The BCBS AZ policy, available at the link below, is the 26 iFuse exclusive policy established by a commercial payer in the US, and provides access to the iFuse Implant System for more than 700,000 BCBS AZ plan members. 44 of the 65 largest private payers in the U.S. now cover the iFuse Implant System for MIS SI joint fusion.
Thirty-four (34) publications were cited as resources supporting the coverage decision with the vast majority documenting the safety, effectiveness and economic benefits of the iFuse Implant, available since 2009. There are now 65 peer-reviewed publications that demonstrate clinical, biomechanic and economic benefits of the iFuse Implant System.
The iFuse Implant System is intended for sacroiliac fusion for conditions including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months. There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and all patients may not benefit.
Globe Newswire: 21:30 GMT Thursday 6th December 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.